Auro Viswabandya is a Staff Physician in the Allogeneic Transplant Program at Princess Margaret Cancer Centre and Associate Professor at the University of Toronto. He also serves as Medical Director of Cancer Quality at Princess Margaret and Quality Director of the BMT & IEC Program and Cell Processing Lab. He holds a Master’s in Healthcare Quality and Safety from Harvard and certifications in Patient Safety (CPPS, IHI) and Healthcare Quality (CPHQ, NAHQ). Nationally and internationally, Dr. Viswabandya contributes to standards, accreditation, and quality oversight through roles with FACT, CSA, ASTCT, CTTC, EBMT, and DEI committees. His clinical expertise centers on haploidentical transplantation and the development of the adult Sickle Cell Transplant and Gene Therapy Program at Princess Margaret. With over 200 peer-reviewed publications, he has built a strong academic and leadership presence in transplantation, quality, equity, and patient safety.